Author Question: A nurse has administered a DTaP immunization to a 7-month-old infant. The nurse educates the parent ... (Read 110 times)

jc611 · **on:** Jul 23, 2018

A nurse has administered a DTaP immunization to a 7-month-old infant. The nurse educates the parent that this is the first of a series of immunizations against which diseases?

Standard Text: Select all that apply.
1. Diptheria
2. Tetanus
3. Varicella
4. Pertussis
5. Hepatitis A

Question 2

A nurse is caring for a client who was just administered hepatitis B immune globulin. The client asks, How long will it take until I'm protected against hepatitis? The nurse's response is based on which understanding?

1. It takes several months for the immune system to respond to the antibodies.
2. The client is protected immediately.
3. It is impossible to determine how long it will take, but blood tests will be performed.
4. Active immunity will occur in 10 days to 2 weeks.

abro1885 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 1,2,4
Rationale 1: The TDaP includes a vaccine against diphtheria.
Rationale 2: The TDaP includes a vaccine against tetanus.
Rationale 3: There is not a vaccine for varicella in the TDaP vaccine.
Rationale 4: There is a vaccine for pertussis in the TDaP vaccine.
Rationale 5: There is not a vaccine for hepatitis A in the TDaP vaccine.
Global Rationale: Tetanus toxoid (TT) is available alone, combined with diphtheria (DT) or combined with both diphtheria and pertussis (DTaP). The initial series of recommended immunizations uses the DTaP and is given in five doses during the first 6 years of the child's life. The vaccine does not include varicella or hepatitis A.

Answer to Question 2

Correct Answer: 2
Rationale 1: It does not take several months for the immune system to respond.
Rationale 2: The client will be protected immediately.
Rationale 3: It is established fact that the client is protected immediately.
Rationale 4: Active immunity does not develop.
Global Rationale: Passive immunization is typically used to provide immediate protection against a recent infection, a potential infection, or a disease in progress. The administration of HBIG is effective in the prevention of clinical hepatitis B infection in approximately 75 of individuals who are treated, but this immune protection is temporary, lasting approximately 2 to 3 months.